Home » Topics » BioWorld Science

BioWorld Science
RSS

AbbVie submits European MAA for risankizumab in moderate to severe plaque psoriasis

May 2, 2018

FDA grants QIDP and fast track designations to oral SCY-078 for vulvovaginal candidiasis

May 2, 2018

Symphogen initiates first-in-human study of Sym-022 in advanced solid tumors or lymphomas

May 2, 2018

MEN-1611 demonstrates promising in vivo activity in various cancer models

May 2, 2018

Shire offers overview of first quarter 2018

May 2, 2018

Kodiak Sciences describes KSI-301, an anti-VEGF therapy with extended half-life

May 2, 2018

MedImmune presents novel bivalent bispecific antibody MEDI-1109

May 2, 2018

Starpharma completes rolling NDA submission for VivaGel BV

May 2, 2018

GlaxoSmithKline reflects on accomplishments of first quarter 2018

May 2, 2018

Crescendo Biologics completes Series B financing

May 2, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...